New vaccine V118C aims to shield kids from pneumococcal disease
NCT ID NCT07300267
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial is testing a new vaccine called V118C to prevent pneumococcal disease, which can cause serious lung and other infections. About 210 toddlers and infants will receive either V118C or an existing vaccine to compare safety and immune response. The study is currently recruiting participants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- V118C vaccine
- What this could lead to
- If successful, this could lead to a new vaccine option to protect children against pneumococcal infections like pneumonia and meningitis.
- What could go wrong
- This is an early phase 1 trial focused on safety, so it's too soon to know if the vaccine works. Side effects like injection-site reactions or fever are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Acevedo Clinical Research Associates ( Site 1029)
RECRUITINGMiami, Florida, 33142, United States
-
Child Health Care Associates ( Site 1035)
RECRUITINGEast Syracuse, New York, 13057, United States
-
Cotton O'Neil Research Center ( Site 1039)
RECRUITINGTopeka, Kansas, 66604, United States
-
Epic Medical Research - Carrollton ( Site 1038)
RECRUITINGCarrollton, Texas, 75006, United States
-
Epic Medical Research- Garland ( Site 1017)
RECRUITINGGarland, Texas, 75043, United States
-
Madera Family Medical Group ( Site 1004)
RECRUITINGMadera, California, 93637, United States
-
Pediatric Research of Charlottesville, LLC ( Site 1012)
RECRUITINGCharlottesville, Virginia, 22902, United States
-
Saint Louis University Center for Vaccine Development ( Site 1031)
RECRUITINGSt Louis, Missouri, 63104, United States
-
The Pediatric Center ( Site 1025)
RECRUITINGColumbia, Maryland, 21045, United States
-
Tribe Clinical Research - Spartanburg ( Site 1001)
RECRUITINGSpartanburg, South Carolina, 29301, United States
-
Tribe Clinical Research, LLC-Pediatrics ( Site 1008)
RECRUITINGGreenville, South Carolina, 29607, United States
-
University of Louisville, Norton Children's Research Institute ( Site 1005)
RECRUITINGLouisville, Kentucky, 40202, United States
-
University of South Florida-Department of Pediatrics ( Site 1002)
RECRUITINGTampa, Florida, 33606, United States
-
University of Texas Medical Branch ( Site 1020)
RECRUITINGLeague City, Texas, 77573, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Broader pneumonia protection for babies? new vaccine trial shows promise
- New vaccine V116 aims to shield vulnerable kids from pneumococcal disease
- Why vaccines may fail in older adults: new study investigates immune cell role
- New vaccine aims to shield High-Risk adults from pneumococcal disease
- Can a pneumonia vaccine protect the most vulnerable children?
- New vaccine aims to shield older adults from pneumonia